Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
TALS Talaris Therapeutics
1.630
-0.140-7.91%
Post Mkt Price
1.6300.0000.00%
Symbol
TALS
Company Name
Talaris Therapeutics
Listing Date
05/07/2021
Establishment Date
2002
CEO
Mr. Scott Requadt
Market
NASDAQ
Employees
127
Securities Type
DR
Fiscal Year Ends
12-31
Address
570 South Preston Street
City
Louisville
Province
Kentucky
Country
United States of America
Zip code
40202
Phone
1-502-398-9250
Profile
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
Company Overview
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO: Mr. Scott Requadt
Market: NASDAQ
Listing Date: 05/07/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist